Literature DB >> 4530281

Asymptomatic infection of adult volunteers with a temperature sensitive mutant of Mycoplasma pneumoniae.

H Greenberg, C M Helms, H Brunner, R M Chanock.   

Abstract

Temperature sensitive mutants of Mycoplasma pneumoniae were developed with the expectation that their temperature sensitive defects would restrict replication in vivo at the temperature of the lower respiratory tract, whereas such defects would not seriously impair replication in the cooler environment of the upper respiratory passages. One such ts mutant, ts-H43, which does not replicate at a temperature of 37 degrees or above, although noninfectious for hamsters, infected each of 16 seronegative adult volunteers when given by the intranasal route. The mutant remained genetically stable throughout the course of infection and stimulated a moderate systemic and local antibody response. The mutant was entirely avirulent for the volunteers but appeared to stimulate resistance to subsequent challenge with partially attenuated wild-type (ts(+)) Mycoplasma pneumoniae.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4530281      PMCID: PMC434318          DOI: 10.1073/pnas.71.10.4015

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease.

Authors:  G W Fernald; W A Clyde
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

2.  A radioimmunoprecipitation test for detection of Mycoplasma pneumoniae antibody.

Authors:  H Brunner; R M Chanock
Journal:  Proc Soc Exp Biol Med       Date:  1973-05

3.  Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers.

Authors:  H Brunner; H B Greenberg; W D James; R L Horswood; R B Couch; R M Chanock
Journal:  Infect Immun       Date:  1973-10       Impact factor: 3.441

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Temperature-sensitive mutants of Mycoplasma pneumoniae. I. In vitro biologic properties.

Authors:  P Steinberg; R L Horswood; R M Chanock
Journal:  J Infect Dis       Date:  1969-08       Impact factor: 5.226

6.  Biologic effects of Mycoplasma pneumoniae and other mycoplasmas from man on hamster tracheal organ culture.

Authors:  A M Collier; W A Clyde; F W Denny
Journal:  Proc Soc Exp Biol Med       Date:  1969-12

Review 7.  Mycoplasma infections of man.

Authors:  R M Chanock
Journal:  N Engl J Med       Date:  1965-11-25       Impact factor: 91.245

8.  Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance.

Authors:  H M Foy; G E Kenny; R McMahan; A M Mansy; J T Grayston
Journal:  JAMA       Date:  1970-11-30       Impact factor: 56.272

9.  Epidemiology of M. pneumoniae infection in military recruits.

Authors:  R M Chanock; H H Fox; W D James; R R Gutekunst; R J White; L B Senterfit
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

10.  Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children.

Authors:  H W Kim; J O Arrobio; C D Brandt; P Wright; D Hodes; R M Chanock; R H Parrott
Journal:  Pediatrics       Date:  1973-07       Impact factor: 7.124

View more
  14 in total

1.  Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters.

Authors:  J V Jemski; C M Hetsko; C M Helms; M B Grizzard; J S Walker; R M Chanock
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

2.  Temperature-sensitive mutants of Actinobacillus pleuropneumoniae induce protection in mice.

Authors:  W Byrd; A M Hooke
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of route of administration on the immunogenicity and protective effect of inactivated M. pneumoniae vaccine.

Authors:  H Greenberg; C M Helms; M B Grizzard; W D James; R L Horswood; R M Chanock
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

4.  Differential growth characteristics and immunogenicity of tight and coasting temperature-sensitive mutants of Pseudomonas aeruginosa.

Authors:  A Morris Hooke; D O Sordelli; M C Cerquetti; J A Bellanti
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

5.  Comparison of enzyme-linked immunosorbent assay and radioimmunoprecipitation test for detection of immunoglobulin A antibodies to Mycoplasma pneumoniae in nasal secretions.

Authors:  Y Naot; E Lis; R Siman-Tov; H Brunner
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

Review 6.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 7.  Mycoplasma pneumoniae infections of adults and children.

Authors:  J D Cherry; R C Welliver
Journal:  West J Med       Date:  1976-07

8.  Protection of rabbits against experimental pasteurellosis by a streptomycin-dependent Pasteurella multocida serotype 3:A live mutant vaccine.

Authors:  Y S Lu; S P Pakes
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines.

Authors:  M F Barile; D K Chandler; H Yoshida; M W Grabowski; S Razin
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

10.  Determination of IgG, IgM, and IgA antibodies to Mycoplasma pneumoniae by an indirect staphylococcal radioimmunoassy.

Authors:  H Brunner; W Schaeg; U Brück; U Schummer; D Sziegoleit; H Schiefer
Journal:  Med Microbiol Immunol       Date:  1978-05-26       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.